Survivorship: Cognitive function, version 1.2014 Journal Article


Authors: Denlinger, C. S.; Ligibel, J. A.; Are, M.; Baker, K. S.; Demark-Wahnefried, W.; Friedman, D. L.; Goldman, M.; Jones, L.; King, A.; Ku, G. H.; Kvale, E.; Langbaum, T. S.; Leonardi-Warren, K.; McCabe, M. S.; Melisko, M.; Montoya, J. G.; Mooney, K.; Morgan, M. A.; Moslehi, J. J.; O'Connor, T.; Overholser, L.; Paskett, E. D.; Raza, M.; Syrjala, K. L.; Urba, S. G.; Wakabayashi, M. T.; Zee, P.; McMillian, N. R.; Freedman-Cass, D. A.
Article Title: Survivorship: Cognitive function, version 1.2014
Abstract: Cognitive impairment is a common complaint among cancer survivors and may be a consequence of the tumors themselves or direct effects of cancer-related treatment (eg, chemotherapy, endocrine therapy, radiation). For some survivors, symptoms persist over the long term and, when more severe, can impact quality of life and function. This section of the NCCN Guidelines for Survivorship provides assessment, evaluation, and management recommendations for cognitive dysfunction in survivors. Nonpharmacologic interventions (eg, instruction in coping strategies; management of distress, pain, sleep disturbances, and fatigue; occupational therapy) are recommended, with pharmacologic interventions as a last line of therapy in survivors for whom other interventions have been insufficient.
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 12
Issue: 7
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2014-07-01
Start Page: 976
End Page: 986
Language: English
PROVIDER: scopus
PMCID: PMC4465252
PUBMED: 24994918
DOI/URL:
Notes: Export Date: 1 August 2014 -- Source: Scopus